Search all trials

Find therapies in clinical trials near you – page 39

Search by disease and location to discover available clinical trials matching your criteria. Updated every day from authoritative EU registries.

recruiting: 3 962
countries: 28
conditions: 2 101

3 962 trials recruiting28 European countries2 101 conditions coveredUpdated today

Quick filters

Pulmonary hypertension

Not recruiting

Registered drug

Study on the Effects of Riociguat and Macitentan in Patients with Inoperable Chronic Thromboembolic Pulmonary Hypertension

Registered drug

France

Participants:18–64 years · 65+ years
Substances:Macitentan

Contact Research Centre

Neoplasm

Not recruiting

Registered drugNo placebo

Study of Regorafenib and Avelumab for Adults with Advanced or Metastatic Solid Tumors

Registered drugNo placebo

France

Participants:18–64 years · 65+ years
Substances:Avelumab

Contact Research Centre

Colorectal cancer metastatic

Not recruiting

Registered drugNo placebo

Study on Napabucasin with FOLFIRI for Adults with Metastatic Colorectal Cancer After Standard Treatments

Registered drugNo placebo

France

Participants:18–64 years · 65+ years
Substances:Fluorouracil

Contact Research Centre

Immune thrombocytopenia

Not recruiting

Registered drugNo placebo

Study comparing dexamethasone versus immunoglobulin plus prednisone for adults with immune thrombocytopenia (ITP) who have moderate to severe bleeding

Registered drugNo placebo

France

Participants:18–64 years · 65+ years
Substances:Dexamethasone

Contact Research Centre

Myelofibrosis+1

Not recruiting

Registered drugNo placebo

Study of Navtemadlin for Patients with Myelofibrosis Resistant to JAK Inhibitors

Registered drugNo placebo

France

Participants:18–64 years · 65+ years
Substances:Danazol

Contact Research Centre

Renal cell carcinoma

Not recruiting

Registered drug

Study of Nivolumab and Ipilimumab for Patients with Advanced Kidney Cancer and Intermediate or Poor Risk Factors

Registered drug

France

Participants:18–64 years · 65+ years
Substances:Ipilimumab

Contact Research Centre

Non-small cell lung cancer

Not recruiting

Registered drugNo placebo

Study on Methotrexate, Dexamethasone, and Montelukast to Prevent Infusion Reactions in Patients with EGFR-Mutated Advanced Non-Small Cell Lung Cancer

Registered drugNo placebo

France

Participants:18–64 years · 65+ years
Substances:Amivantamab

Contact Research Centre

Study Comparing Epcoritamab with Chemotherapy for Patients with Relapsed or Refractory B-cell Lymphoma

Not recruiting

Registered drugNo placebo

Study Comparing Epcoritamab with Chemotherapy for Patients with Relapsed or Refractory B-cell Lymphoma

Registered drugNo placebo

France

Participants:18–64 years · 65+ years
Substances:Anakinra

Contact Research Centre

Factor VIII deficiency+1

Not recruiting

InvestigationalNo placebo

Study on How Concizumab Works for Patients with Hemophilia A or B Without Inhibitors

InvestigationalNo placebo

France

Participants:0–17 years · 18–64 years · 65+ years
Substances:Concizumab

Contact Research Centre

Multiple sclerosis+1

Not recruiting

Registered drug

Study on the Effects of a Higher Dose of Ocrelizumab for Adults with Primary Progressive Multiple Sclerosis

Registered drug

France

Participants:18–64 years
Substances:Methylprednisolone

Contact Research Centre

Non-small cell lung cancer+2

Not recruiting

Registered drug

Study of Niraparib and Pembrolizumab for Patients with Advanced Non-Small Cell Lung Cancer

Registered drug

France

Participants:18–64 years · 65+ years
Substances:Pembrolizumab

Contact Research Centre

Non-small cell lung cancer

Not recruiting

Registered drugNo placebo

Study on Durvalumab and Platinum-Based Drug Combination for Patients with Stage IIB-IIIB Non-Small Cell Lung Cancer

Registered drugNo placebo

France

Participants:18–64 years · 65+ years
Substances:Anhydrous Docetaxel

Contact Research Centre

Find therapies in clinical trials near you – page 39

584 trials match your criteria

Pulmonary hypertension

Study on the Effects of Riociguat and Macitentan in Patients with Inoperable Chronic Thromboembolic Pulmonary Hypertension

Neoplasm

Study of Regorafenib and Avelumab for Adults with Advanced or Metastatic Solid Tumors

Colorectal cancer metastatic

Study on Napabucasin with FOLFIRI for Adults with Metastatic Colorectal Cancer After Standard Treatments

Immune thrombocytopenia

Study comparing dexamethasone versus immunoglobulin plus prednisone for adults with immune thrombocytopenia (ITP) who have moderate to severe bleeding

Myelofibrosis+1

Study of Navtemadlin for Patients with Myelofibrosis Resistant to JAK Inhibitors

Renal cell carcinoma

Study of Nivolumab and Ipilimumab for Patients with Advanced Kidney Cancer and Intermediate or Poor Risk Factors

Non-small cell lung cancer

Study on Methotrexate, Dexamethasone, and Montelukast to Prevent Infusion Reactions in Patients with EGFR-Mutated Advanced Non-Small Cell Lung Cancer

Study Comparing Epcoritamab with Chemotherapy for Patients with Relapsed or Refractory B-cell Lymphoma

Study Comparing Epcoritamab with Chemotherapy for Patients with Relapsed or Refractory B-cell Lymphoma

Factor VIII deficiency+1

Study on How Concizumab Works for Patients with Hemophilia A or B Without Inhibitors

Multiple sclerosis+1

Study on the Effects of a Higher Dose of Ocrelizumab for Adults with Primary Progressive Multiple Sclerosis

Non-small cell lung cancer+2

Study of Niraparib and Pembrolizumab for Patients with Advanced Non-Small Cell Lung Cancer

Non-small cell lung cancer

Study on Durvalumab and Platinum-Based Drug Combination for Patients with Stage IIB-IIIB Non-Small Cell Lung Cancer

Explore other searches

Vaccine trials

Paediatric trials · ages 0–17

Healthy volunteers

Helpful resources

How applying through us works

What happens after you apply

Guides for patients and volunteers

Search filters

Prefer not to search? Our Concierge searches the trials for you.